CVS Health Corporation (CVS)
55.29 USD -1.57 (-2.76%) Volume: 8.98M
CVS Health Corporation’s stock price stands at 55.29 USD, experiencing a downturn of -2.76% this trading session with a trading volume of 8.98M, reflecting a significant YTD decrease of -29.64%, showcasing the volatile nature of CVS’s market performance.
Latest developments on CVS Health Corporation
Despite recent acquisitions and stock purchases by various investment firms, CVS Health Corp. stock has been underperforming compared to its competitors. The company’s announcement of a $950 million senior notes tender offer at $998.22 per $1,000 principal did little to boost stock prices, which have been on a downward trend since the last earnings report. Additionally, the appointment of a new retail pharmacy chief and the closure of all MinuteClinics in Utah by the end of the week have also impacted investor sentiment. CVS is now seeking relief from debt pain with a $3 billion hybrid, as stockholders eagerly await any positive movements in the coming days.
CVS Health Corporation on Smartkarma
Analysts at Baptista Research have been closely monitoring CVS Health Corp’s performance and strategic direction. In their report titled “CVS Health Corporation: Expansion & Optimization of Health Services As A Critical Factor Driving Growth! – Major Drivers,” they highlight the company’s revenue reaching approximately $95.4 billion, a 6% increase from the previous year. However, challenges, particularly within the Health Care Benefits (HCB) segment, are indicated by the adjusted earnings per share (EPS) of $1.09.
Another report by Baptista Research, “CVS Health Corporation: Strategic Leverage in Pharmacy Benefit Management (PBM) and Insurance Operations! – Major Drivers,” focuses on CVS Health’s second-quarter financial results. Despite mixed results, the company achieved an adjusted earnings per share of $1.83 and revenues exceeding $91 billion. Strong performance in the Health Services and Pharmacy & Consumer Wellness segments contributed to an operating cash flow of $8 billion for the first half of the year.
A look at CVS Health Corporation Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 5 | |
| Dividend | 5 | |
| Growth | 3 | |
| Resilience | 3 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 3.8 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
According to Smartkarma Smart Scores, CVS Health Corp has received high scores in Value and Dividend, indicating a positive long-term outlook for the company. With a strong focus on providing pharmacy benefit management services, mail order, retail and specialty pharmacy, as well as disease management programs, CVS Health Corp is well-positioned in the healthcare industry. Additionally, the company operates drugstores across the United States, the District of Columbia, and Puerto Rico, showcasing its extensive reach and presence in the market.
Although CVS Health Corp received slightly lower scores in Growth, Resilience, and Momentum, the company’s solid foundation in value and dividend payout suggests stability and potential for growth in the future. With a diverse range of healthcare services and retail clinics, CVS Health Corp remains a key player in the industry, catering to the evolving needs of consumers and maintaining a strong market position.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
